This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Zoltan Bugir: Innovator in Pharmaceutical Chemistry
Introduction
Zoltan Bugir is a notable inventor based in Erd, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods in drug preparation. His work has implications for the development of important therapeutic agents.
Latest Patents
Zoltan Bugir holds a patent for a method titled "Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of same." This patent details the preparation of Fexinidazole, which involves several key steps. The process includes reacting 1-methyl-2-hydroxymethyl-5-nitro-imidazole with methanesulfonyl chloride, followed by the addition of a solution of 4-methyl-mercapto-phenol. The final steps involve separating Fexinidazole from the reaction mixture and purifying it as needed. He has 1 patent to his name.
Career Highlights
Zoltan Bugir is currently employed at Sanofi, a global leader in the pharmaceutical industry. His role involves research and development, where he applies his expertise in chemistry to create innovative solutions for health challenges. His work contributes to the advancement of new medications that can improve patient outcomes.
Collaborations
Zoltan has collaborated with several talented individuals in his field, including Edit Alattyani and Marton Harsanyi. These collaborations enhance the research environment and foster innovation within the pharmaceutical sector.
Conclusion
Zoltan Bugir's contributions to pharmaceutical chemistry through his patent and work at Sanofi highlight his role as an innovator in the industry. His dedication to advancing drug development is commendable and reflects the importance of collaboration in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
